Literature DB >> 20042543

Does inhibition of apolipoprotein B synthesis produce foie gras?

Kenneth R Feingold1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20042543      PMCID： PMC2853454          DOI： 10.1194/jlr.E005140

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  15 in total

Review 1.  Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia.

Authors:  John R Burnett
Journal:  Curr Opin Mol Ther       Date:  2006-10

2.  An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis.

Authors:  Rosanne M Crooke; Mark J Graham; Kristina M Lemonidis; Charles P Whipple; Seonjoon Koo; Ranjan J Perera
Journal:  J Lipid Res       Date:  2005-02-16       Impact factor: 5.922

Review 3.  Familial hypobetalipoproteinemia: genetics and metabolism.

Authors:  G Schonfeld; X Lin; P Yue
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

4.  Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia.

Authors:  Raaj R Sankatsing; Sigrid W Fouchier; Stefan de Haan; Barbara A Hutten; Eric de Groot; John J P Kastelein; Erik S G Stroes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-07-07       Impact factor: 8.311

5.  Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.

Authors:  John J P Kastelein; Mark K Wedel; Brenda F Baker; John Su; JoAnn D Bradley; Rosie Z Yu; Emil Chuang; Mark J Graham; Rosanne M Crooke
Journal:  Circulation       Date:  2006-10-09       Impact factor: 29.690

Review 6.  The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.

Authors:  Stephen D Wiviott; Christopher P Cannon
Journal:  Curr Opin Lipidol       Date:  2006-12       Impact factor: 4.776

7.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

8.  CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.

Authors:  Charles E Chandler; Donald E Wilder; Judith L Pettini; Yvette E Savoy; Stephen F Petras; George Chang; John Vincent; H James Harwood
Journal:  J Lipid Res       Date:  2003-07-01       Impact factor: 5.922

Review 9.  A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.

Authors:  Dalya Marks; Margaret Thorogood; H Andrew W Neil; Steve E Humphries
Journal:  Atherosclerosis       Date:  2003-05       Impact factor: 5.162

10.  Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.

Authors:  Tariq Tanoli; Pin Yue; Dmitriy Yablonskiy; Gustav Schonfeld
Journal:  J Lipid Res       Date:  2004-02-16       Impact factor: 5.922
View more
  1 in total

1.  Novel method for reducing plasma cholesterol: a ligand replacement therapy.

Authors:  G M Anantharamaiah; Dennis Goldberg
Journal:  Clin Lipidol       Date:  2015-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.